Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD naming Billy Kelleher .
Filed returns
23
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | MSD | Health | EU Cardiovascular Diseases Strategy (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | One Substance, One Assessment' (OSOA) chemical assessment EU reform (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | New Medicines Funding (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Reform of the EU pharmaceutical legislation (Legislation) | 7 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | European policy on innovative pharmaceutical medicine (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Meetings to highlight the importance of predictability in IP rights in EU Pharmaceutical Legislation revision (Legislation) | 5 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | EU Pharmaceutical Legislation (Legislation) | 7 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Agriculture | Hosted by Colm Markey MEP in Brussels to discuss the position of agtech in Ireland and Europe’s ecosystem. AgTech Ireland is the first EU organisation dedicated to the agtech needs of an EU member state. The topics… (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | EU Pharmaceutical Legislation (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2022 | MSD | Health | Oncology Policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Health | Oncology Policy (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 91 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Access to Innovation in Oncology (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Oncology Policy (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Access and Reimbursement of Medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Immunisation Programmes (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Immunisation Policy (Public policy or programme) | 18 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Immunisation Programmes (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Future Healthcare Policy (Public policy or programme) | 25 | On lobbying.ie |
| May–Aug 2016 | MSD | Health | The reimbursement of new oncology medicines (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2015 | MSD | Health | Health Bill 2012 (Legislation) | 4 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 21 | 91.3% | |
| Agriculture | 1 | 4.3% | |
| Economic Development and Industry | 1 | 4.3% |